1. Drug-eluting and bare metal stents

Randomised trial of durable polymer zotarolimus-eluting versus biodegradable polymer sirolimus-eluting stents

BIONYX
Objective
to compare ZES with durable polymer versus SES with biodegradable polymer
Study
randomised, multicentre, non-inferiority trial
Population
all-comer population at 7 centres in Belgium, Netherlands, Israel
Endpoints
target vessel failure at 12 months
Conclusion
ZES was non-inferior to SES for clinical outcomes at 1 year
Von Birgelen et al. Lancet. 2018;392:1235-45
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved